Gene · 6103
Papers1,847
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,847
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Skewed X-inactivation is associated with retinal dystrophy in female carriers of RPGR mutations. | Life Sci Alliance | 2023 | 37541846 | PubTator, text mining | PubMed |
| Assessing geochemical and natural radioactivity impacts of Hamadat phosphatic mine through radiological indices. | PLoS One | 2023 | 37535632 | PubTator, text mining | PubMed |
| A Description of the Yield of Genetic Reinvestigation in Patients with Inherited Retinal Dystrophies and Previous Inconclusive Genetic Testing. | Genes (Basel) | 2023 | 37510321 | PubTator, text mining | PubMed |
| Pearls and Pitfalls of Adaptive Optics Ophthalmoscopy in Inherited Retinal Diseases. | Diagnostics (Basel) | 2023 | 37510157 | PubTator, text mining | PubMed |
| RPGR-Associated Cone-Rod Degeneration and Tapetal-Like Reflex in a Male Patient. | Ophthalmol Retina | 2023 | 37498269 | PubTator, text mining | PubMed |
| Protein target highlights in CASP15: Analysis of models by structure providers. | Proteins | 2023 | 37493353 | PubTator, text mining | PubMed |
| Nanotechnology-based ocular drug delivery systems: recent advances and future prospects. | J Nanobiotechnology | 2023 | 37480102 | PubTator, text mining | PubMed |
Qualitative exploration of the visual function impairments and impacts on vision-dependent activities of daily living in Retinitis Pigmentosa and Leber Congenital Amaurosis: content validation of the ViSIO-PRO and ViSIO-ObsRO measures. | J Patient Rep Outcomes | 2023 | 37466759 | PubTator, text mining | PubMed |
| Study on Ignition Delay and Reaction Mechanism of RP-3/Air Combustion Adding C6F12O. | ACS Omega | 2023 | 37457478 | PubTator, text mining | PubMed |
| MTG-Link: leveraging barcode information from linked-reads to assemble specific loci. | BMC Bioinformatics | 2023 | 37452278 | PubTator, text mining | PubMed |
| Clinical Characteristics and Genetic Variants of a Large Cohort of Patients with Retinitis Pigmentosa Using Multimodal Imaging and Next Generation Sequencing. | Int J Mol Sci | 2023 | 37446072 | PubTator, text mining | PubMed |
| Clinical and Molecular Aspects of C2orf71/PCARE in Retinal Diseases. | Int J Mol Sci | 2023 | 37445847 | PubTator, text mining | PubMed |
| Highly Resistant Serotype 19A Streptococcus pneumoniae of the GPSC1/CC320 Clone from Invasive Infections in Poland Prior to Antipneumococcal Vaccination of Children. | Infect Dis Ther | 2023 | 37442903 | PubTator, text mining | PubMed |
| Systematic Underestimation of Visual Sensitivity Loss on Microperimetry: Implications for Testing Protocols in Clinical Trials. | Transl Vis Sci Technol | 2023 | 37428130 | PubTator, text mining | PubMed |
| Lymph node metastasis-related gene signature shows good performance in predicting prognosis and immune infiltration in cervical cancer. | Front Oncol | 2023 | 37427104 | PubTator, text mining | PubMed |
| Human beta defensin-3 mediated activation of β-catenin during human respiratory syncytial virus infection: interaction of HBD3 with LDL receptor-related protein 5. | Front Microbiol | 2023 | 37426017 | PubTator, text mining | PubMed |
| Retinal degeneration in rpgra mutant zebrafish. | Front Cell Dev Biol | 2023 | 37351277 | PubTator, text mining | PubMed |
| Next-generation sequencing--based genetic testing and phenotype correlation in retinitis pigmentosa patients from India. | Indian J Ophthalmol | 2023 | 37322672 | PubTator, text mining | PubMed |
| Inference and reconstruction of the heimdallarchaeial ancestry of eukaryotes. | Nature | 2023 | 37316666 | PubTator, text mining | PubMed |
| Biochemical-molecular-genetic biomarkers in the tear film, aqueous humor, and blood of primary open-angle glaucoma patients. | Front Med (Lausanne) | 2023 | 37305138 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6103/papers?page=12